Stress‐induced anhedonia is associated with an increase in Alzheimer's disease‐related markers

Abstract

Vulnerability to stress might constitute a risk factor for the development of AD, and pharmacological treatment with venlafaxine may represent a therapeutic strategy for the treatment of stress-related disorders, including AD.